4 results
Approved WMOWill not start
To evaluate the safety and effectiveness of the BackBeat Moderato system.
Approved WMOCompleted
(protocol section 2) This phase 1 study aims to assess the safety and tolerability of monoclonal antibody TB31F administered intravenously or at escalating dose levels or subcutaneously in healthy, malaria naïve, adults. This study will also…
Approved WMORecruiting
Primary Objective: The treatment result expressed as the proportion of successful treatments per treatment arm (successful = VUR <= grade 1 and/or no urinary-tract infections 6 months after the operation) does at least not show a significant…
Approved WMOCompleted
To evaluate the safety and performance of the BackBeat Moderato system.